Flatow-Trujillo Lainey, Win Khine, Jencks Amy, Andritsos Leslie, Arana Yi Cecilia
University of Mexico School of Medicine Albuquerque New Mexico.
University of California San Francisco Marysville California.
Clin Case Rep. 2019 Sep 27;7(11):2082-2086. doi: 10.1002/ccr3.2408. eCollection 2019 Nov.
Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous group of lymphomas which require multiagent therapy for remission induction and are associated with relapse in more than 40% of patients. Spontaneous remission of diffuse large B-cell lymphoma (DLBCL) is a rare occurrence.
弥漫性大B细胞淋巴瘤(DLBCL)是一组异质性淋巴瘤,需要采用多药联合治疗来诱导缓解,且超过40%的患者会复发。弥漫性大B细胞淋巴瘤(DLBCL)的自发缓解极为罕见。